DE69312698T2 - Trizyklische tachikinin-antagonisten, deren herstellung und diese enthaltende pharmazeutische präparate - Google Patents

Trizyklische tachikinin-antagonisten, deren herstellung und diese enthaltende pharmazeutische präparate

Info

Publication number
DE69312698T2
DE69312698T2 DE69312698T DE69312698T DE69312698T2 DE 69312698 T2 DE69312698 T2 DE 69312698T2 DE 69312698 T DE69312698 T DE 69312698T DE 69312698 T DE69312698 T DE 69312698T DE 69312698 T2 DE69312698 T2 DE 69312698T2
Authority
DE
Germany
Prior art keywords
compounds
formula
substituents
group
nhco
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69312698T
Other languages
German (de)
English (en)
Other versions
DE69312698D1 (de
Inventor
Angelina Lombardi
Carlo Alberto Maggi
Vincenzo Pavone
Carlo Pedone
Laura Quartara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A Menarini Industrie Farmaceutiche Riunite SRL
Laboratorio Guidotti SpA
Malesci Instituto Farmacobiologico SpA
Original Assignee
A Menarini Industrie Farmaceutiche Riunite SRL
Laboratorio Guidotti SpA
Malesci Instituto Farmacobiologico SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A Menarini Industrie Farmaceutiche Riunite SRL, Laboratorio Guidotti SpA, Malesci Instituto Farmacobiologico SpA filed Critical A Menarini Industrie Farmaceutiche Riunite SRL
Application granted granted Critical
Publication of DE69312698D1 publication Critical patent/DE69312698D1/de
Publication of DE69312698T2 publication Critical patent/DE69312698T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69312698T 1992-04-15 1993-04-13 Trizyklische tachikinin-antagonisten, deren herstellung und diese enthaltende pharmazeutische präparate Expired - Fee Related DE69312698T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITFI920089A IT1262902B (it) 1992-04-15 1992-04-15 Composti triciclici antagonisti delle tachichinine, loro preparazione e loro uso in composizioni farmaceutiche.
PCT/EP1993/000893 WO1993021227A1 (en) 1992-04-15 1993-04-13 Tachykinin antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds

Publications (2)

Publication Number Publication Date
DE69312698D1 DE69312698D1 (de) 1997-09-04
DE69312698T2 true DE69312698T2 (de) 1997-12-04

Family

ID=11350056

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69312698T Expired - Fee Related DE69312698T2 (de) 1992-04-15 1993-04-13 Trizyklische tachikinin-antagonisten, deren herstellung und diese enthaltende pharmazeutische präparate

Country Status (28)

Country Link
EP (1) EP0636146B1 (enExample)
JP (1) JPH08500331A (enExample)
KR (1) KR950700935A (enExample)
CN (1) CN1039126C (enExample)
AT (1) ATE156135T1 (enExample)
AU (1) AU671118B2 (enExample)
BG (1) BG99110A (enExample)
BR (1) BR9306248A (enExample)
CA (1) CA2118253A1 (enExample)
CZ (1) CZ254294A3 (enExample)
DE (1) DE69312698T2 (enExample)
DK (1) DK0636146T3 (enExample)
ES (1) ES2105265T3 (enExample)
FI (1) FI944838A7 (enExample)
GR (1) GR3024348T3 (enExample)
HR (1) HRP930814A2 (enExample)
HU (1) HUT70189A (enExample)
IL (1) IL105381A (enExample)
IT (1) IT1262902B (enExample)
MX (1) MX9302161A (enExample)
NO (1) NO943861L (enExample)
NZ (1) NZ251969A (enExample)
RO (1) RO112872B1 (enExample)
RU (1) RU94045890A (enExample)
SK (1) SK124294A3 (enExample)
TW (1) TW234718B (enExample)
WO (1) WO1993021227A1 (enExample)
ZA (1) ZA932644B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1277835B1 (it) * 1995-03-13 1997-11-12 Menarini Farma Ind Composti biciclici, loro preparazione ed uso in composizioni farmaceutiche
IT1283171B1 (it) * 1996-03-01 1998-04-16 Interdipartimentale Di Ricerca Composti solubili antagonisti delle tachichinine loro preparazione e loro uso in composizioni farmaceutiche
IT1291776B1 (it) 1997-02-07 1999-01-21 Menarini Ricerche Spa Composti monociclici a quattro residui bifunzionali, aventi azione nk-2 antagonista
IT1307809B1 (it) 1999-10-21 2001-11-19 Menarini Ricerche Spa Composti monociclici basici ad azione nk-2 antagonista, processi difabbricazione e formulazioni che li contengono.
EP1297826A1 (en) * 2001-09-27 2003-04-02 Menarini Ricerche S.p.A. Nasal pharmaceutical compositions containing a NK-2 antagonist

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8807246D0 (en) * 1988-03-25 1988-04-27 Merck Sharp & Dohme Therapeutic agents
DE3915361A1 (de) * 1989-05-11 1990-11-15 Merck Patent Gmbh Cyclopeptide

Also Published As

Publication number Publication date
ITFI920089A0 (it) 1992-04-15
AU671118B2 (en) 1996-08-15
SK124294A3 (en) 1995-07-11
ES2105265T3 (es) 1997-10-16
WO1993021227A1 (en) 1993-10-28
CN1080916A (zh) 1994-01-19
TW234718B (enExample) 1994-11-21
FI944838L (fi) 1994-10-14
GR3024348T3 (en) 1997-11-28
MX9302161A (es) 1994-05-31
RU94045890A (ru) 1996-09-10
RO112872B1 (ro) 1998-01-30
CZ254294A3 (en) 1995-07-12
IT1262902B (it) 1996-07-22
AU4039593A (en) 1993-11-18
ZA932644B (en) 1993-10-22
NO943861D0 (no) 1994-10-13
CN1039126C (zh) 1998-07-15
HU9402977D0 (en) 1995-02-28
NZ251969A (en) 1997-12-19
IL105381A (en) 1998-02-22
HUT70189A (en) 1995-09-28
FI944838A0 (fi) 1994-10-14
DK0636146T3 (da) 1998-02-23
EP0636146B1 (en) 1997-07-30
DE69312698D1 (de) 1997-09-04
EP0636146A1 (en) 1995-02-01
ATE156135T1 (de) 1997-08-15
BG99110A (bg) 1995-09-29
FI944838A7 (fi) 1994-10-14
ITFI920089A1 (it) 1993-10-15
KR950700935A (ko) 1995-02-20
JPH08500331A (ja) 1996-01-16
HRP930814A2 (en) 1996-12-31
NO943861L (no) 1994-10-13
CA2118253A1 (en) 1993-10-28
BR9306248A (pt) 1998-06-23

Similar Documents

Publication Publication Date Title
KR101904808B1 (ko) 데가렐릭스 및 이의 중간 화합물의 제조 방법
DE69132708T2 (de) Therapeutische Vervendung von Peptiden mit Thrombospondin - ähnlicher Aktivität
EP0502198B1 (en) Novel polypeptide and anti-hiv drug prepared therefrom
AU759442B2 (en) Novel LHRH antagonists with improved solubility characteristics
US5128447A (en) Synthetic peptide antagonists of neurokinin a, salts thereof and respective preparation processes
US5786335A (en) Sulfhydryl containing peptides for treating vascular disease
DE69312698T2 (de) Trizyklische tachikinin-antagonisten, deren herstellung und diese enthaltende pharmazeutische präparate
US5731285A (en) Tachiquinine antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds
DE69611438T2 (de) Bizyclische tachykinin-antagonisten, deren herstellung und deren verwendung in pharmazeutischen zusammmensetzungen
DE2751026A1 (de) Verfahren zur herstellung von peptiden, die tyrosinsulfat enthalten
DE69104987T2 (de) Synthetische peptide mit neurokinin a antagonistischer wirkung, deren salze und verfahren zu deren herstellung.
WO1991006563A1 (en) Reduced irreversible bombesin antagonists
CA2405724C (en) Substance p analogs for the treatment of cancer
US5786447A (en) Opioid peptide analogs

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee